DEC 19, 2018 9:09 PM PST

Breast Cancer - Immunotherapy's Nemesis

WRITTEN BY: Nicholas Breehl

Immunotherapy is continuing to be an exciting prospect for physicians and patients alike when combating cancer. Making use of one’s immune system to remove the threat is becoming increasingly effective, and for that reason, new studies continue to explore the science that surrounds it. Unfortunately, a recent study reveals that breast cancer can evade the immune system.

Breast cancers can start from different parts of the breast. Most breast cancers begin in the ducts that carry milk to the nipple (ductal cancers). Some start in the glands that make breast milk (lobular cancers).

There are also other types of breast cancer that are less common. A small number of cancers start in other tissues in the breast. These cancers are called sarcomas and lymphomas and are not thought of as breast cancers.

Although many types of breast cancer can cause a lump in the breast, not all do.  Many breast cancers are found on screening mammograms which can detect cancers at an earlier stage, often before they can be felt, and before symptoms develop.

Associate Professor of Statistics Jinfeng Zhang, Professor of Chemistry and Biochemistry Qing-Xiang "Amy" Sang, and graduate students Mayassa Burjas Bou Dargham and Yuhang Liu analyzed data from more than 1,000 breast cancer patients and found that breast cancer behaves differently than other cancers that are currently treated with immunotherapy.

"We've been trying to understand why breast cancer patients do not respond well to the current immunotherapy and cannot benefit from this major breakthrough," Sang said. Their work is published in the journal PLOS ONE.

Researchers said the problem lies in the many different mechanisms breast cancer uses to hide from the immune system.

The team broke the data down into different groups and identified seven clusters of breast cancer patients based on the immune evasion mechanisms that breast cancer uses to avoid detection. Some of the types even used a combination of ways to hide from the immune system.

The more data and information that the scientists can gather will allow for oncologists to better equip themselves when treating breast cancer patients.

"Cancer treatment isn't as personalized as it should be," Burjas Bou Dargham said. "We've been trying to understand what's going on with these tumors and how they operate. That way doctors can ultimately better treat their patients."

"There's so much data available to understand problems in cancer," describes Zhang.

"Immunotherapy is a big breakthrough, but still we don't understand why some patients respond and others don't."

The researchers are gearing up to continue their research by gathering more data about an aggressive subtype of breast cancer known as triple-negative breast cancer.

Sources: PLOS ONE, Science Daily, American Cancer Society, YouTube

About the Author
Masters
You May Also Like
JUN 16, 2022
Clinical & Molecular DX
Overuse of Asthma Inhalers Leads to More Severe Asthma and Hospitalization
JUN 16, 2022
Overuse of Asthma Inhalers Leads to More Severe Asthma and Hospitalization
Asthma is a chronic lung condition characterized by inflammation and narrowness in the airways that carry air in and out ...
JUL 28, 2022
Clinical & Molecular DX
The benefits of lyophilization in assay kit development: Maximizing the integrity and shelf life of reagents
JUL 28, 2022
The benefits of lyophilization in assay kit development: Maximizing the integrity and shelf life of reagents
Freeze drying, lyophilization, and cryodesiccation are all terms used to describe the process of removing water from a s ...
JUL 16, 2022
Microbiology
Breastmilk Can Reduce Infection Risk, with a Tradeoff
JUL 16, 2022
Breastmilk Can Reduce Infection Risk, with a Tradeoff
Breastfeeding is encouraged because it provides many benefits to both mothers and infants. Breastmilk is nutritious, and ...
JUL 29, 2022
Immunology
Resistance to Human Interferons Emerges in SARS-CoV-2 Variants
JUL 29, 2022
Resistance to Human Interferons Emerges in SARS-CoV-2 Variants
SARS-CoV-2 is the virus that causes COVID-19. Since we first encountered it in late 2019, the virus has continued to mut ...
AUG 02, 2022
Neuroscience
Could Common Viruses be Triggering Alzheimer's?
AUG 02, 2022
Could Common Viruses be Triggering Alzheimer's?
Recent allegations of research misconduct have called years of Alzheimer's research into question. The controversy surro ...
AUG 16, 2022
Immunology
Two Studies Describe Powerful Antibodies That Neutralize SARS-CoV-2
AUG 16, 2022
Two Studies Describe Powerful Antibodies That Neutralize SARS-CoV-2
SARS-CoV-2, which causes COVID-19, has mutated many times into new variants, some that we don't hear about, while others ...
Loading Comments...